Related Experiment Videos
New phloroglucinol derivatives from Hypericum papuanum
K Winkelmann1, J Heilmann, O Zerbe
1Department of Pharmacy, Swiss Federal Institute of Technology (ETH) Zurich, CH-8057 Zürich, Switzerland.
Journal of Natural Products
|January 29, 2000
Summary
Five new tricyclic phloroglucinol derivatives, named ialibinones A-E, were isolated from Hypericum papuanum. Compounds 1-4 demonstrated antibacterial activity against common bacterial strains.
Area of Science:
- Natural Product Chemistry
- Phytochemistry
- Medicinal Chemistry
Background:
- Hypericum species are known sources of bioactive compounds.
- Tricyclic phloroglucinol derivatives represent a class of natural products with diverse biological activities.
- The chemical constituents of Hypericum papuanum have not been extensively studied.
Purpose of the Study:
- To isolate and characterize new bioactive compounds from Hypericum papuanum.
- To investigate the antibacterial potential of the isolated compounds.
Main Methods:
- Bioactivity-guided fractionation of the petroleum ether extract of aerial parts of Hypericum papuanum.
- Structure elucidation using extensive 1D and 2D NMR spectroscopy and Mass Spectrometry (MS).
- Antibacterial activity testing against Bacillus cereus, Staphylococcus epidermidis, and Micrococcus luteus.
Main Results:
- Five new tricyclic phloroglucinol derivatives, designated ialibinones A-E (compounds 1-5), were isolated.
- The structures were elucidated as C-3 epimers of specific tricyclo[5.3.1.0(1,5)]undec-8-ene-10,11-dione derivatives and their tautomers.
- Compounds 1-4 exhibited antibacterial activity against Bacillus cereus, Staphylococcus epidermidis, and Micrococcus luteus.
Conclusions:
- Hypericum papuanum is a source of novel tricyclic phloroglucinol derivatives.
- Ialibinones A-D possess significant antibacterial properties.
- Further investigation into the medicinal potential of these compounds is warranted.